<?xml-stylesheet type="text/xsl" href="https://community.appian.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Study Design and Execution: Re-starting clinical trials in a post-pandemic world [Solutions &amp;amp; Industries]</title><link>/events/b/appian-world-2020/posts/study-design-and-execution-re-starting-clinical-trials-in-a-post-pandemic-world-solutions-industries</link><description>In 2020, many clinical trials were brought to a halt by the COVID-19 pandemic. As communities across the globe work to flatten the curve and look toward post-pandemic life, life sciences organizations will be jumping back into their clinical trials .</description><dc:language>en-US</dc:language><generator>Telligent Community 12</generator></channel></rss>